XT
IRWD icon

XTX Topco’s Ironwood Pharmaceuticals IRWD Stock Holding History

XTX Topco’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43,904
Closed -$148K – 4074
2025
Q4 		$148K Buy
43,904
+32,657
+290% +$84.8K ﹤0.01% 2508
2025
Q3 		$14.7K Buy
+11,247
New +$11.6K ﹤0.01% 2380
2025
Q2 		– Sell
-552,613
Closed -$812K – 2757
2025
Q1 		$812K Buy
552,613
+506,732
+1,104% +$1.21M 0.04% 682
2024
Q4 		$203K Buy
+45,881
New +$186K 0.02% 1547
2024
Q2 		– Sell
-55,658
Closed -$485K – 2148
2024
Q1 		$485K Buy
55,658
+9,213
+20% +$112K 0.07% 502
2023
Q4 		$531K Buy
46,445
+30,432
+190% +$301K 0.12% 222
2023
Q3 		$154K Sell
16,013
-34,638
-68% -$339K 0.03% 1098
2023
Q2 		$539K Buy
+50,651
New +$544K 0.1% 324
2022
Q3 		– Sell
-34,810
Closed -$401K – 1239
2022
Q2 		$401K Buy
+34,810
New +$410K 0.16% 175
2021
Q2 		– Sell
-13,698
Closed -$153K – 946
2021
Q1 		$153K Buy
+13,698
New +$145K 0.07% 528

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

XTX Topco's IRWD Position: Q1 2026 in Review

XTX Topco sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 43,904 shares — an estimated $148K sold.

XTX Topco first reported a position in IRWD in Q1 2021 and held it in 10 quarters. The position peaked at $812K in Q1 2025. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • XTX Topco reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • XTX Topco sold 43,904 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $148K.
  • XTX Topco first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 10 quarters.
  • XTX Topco's Ironwood Pharmaceuticals position peaked at $812K in Q1 2025.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.